C-ISLE: Grazoprevir/Elbasvir plus Sofosbuvir in Treatment-naive and Treatment-experienced HCV GT3 Cirrhotic Patients Treated for 8, 12 or 16 weeks

被引：0

作者：

Foster, Graham R. ^{[1
]}

Agarwal, Kosh ^{[2
]}

Cramp, Matthew ^{[3
,4
]}

Moreea, Sulleman ^{[5
]}

Barclay, Stephen T. ^{[6
]}

Collier, Jane ^{[7
]}

Brown, Ashley S. ^{[8
]}

Ryder, Stephen D. ^{[9
,10
]}

Ustianowski, Andrew ^{[11
]}

Forton, Daniel M. ^{[12
]}

Fox, Ray ^{[13
]}

Gordon, Fiona ^{[14
]}

Rosenberg, William M. ^{[15
]}

Mutimer, David J. ^{[16
]}

Du, Jiejun ^{[17
]}

Gilbert, Christopher L. ^{[17
]}

Wahl, Janice ^{[17
]}

Barr, Eliav ^{[17
]}

Haber, Barbara ^{[17
]}

机构：

[1] Royal London Hosp, London, England

[2] Kings Coll Hosp London, Inst Liver Studies, London, England

[3] Derriford Hosp, South West Liver Unit, Plymouth, Devon, England

[4] Peninsula Sch Med & Dent, Plymouth, Devon, England

[5] Bradford Teaching Hosp Fdu Trust, Bradford, W Yorkshire, England

[6] Glasgow Royal Campus, Glasgow, Lanark, Scotland

[7] John Radcliffe Hosp, Oxford, England

[8] Imperial Coll Healthcare, London, England

[9] Nottingham Univ Hopsitals NHS Trust, NIHR Biomed Unit Gastrointestinal & Liver Dis, Nottingham, England

[10] Univ Nottingham, Nottingham, England

[11] North Manchester Gen Hosp, Manchester, Lancs, England

[12] St Georges Univ London, London, England

[13] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland

[14] Hepatol Joint Clin Res Unit, Bristol, Avon, England

[15] UCL, London, England

[16] QE Hosp, Birmingham, W Midlands, England

[17] Merck & Co Inc, Kenilworth, NJ USA

来源：

HEPATOLOGY | 2016年 / 64卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：39A / 40A

页数：2